0001606031-14-000003.txt : 20140428
0001606031-14-000003.hdr.sgml : 20140428
20140428151415
ACCESSION NUMBER: 0001606031-14-000003
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20140428
DATE AS OF CHANGE: 20140428
EFFECTIVENESS DATE: 20140428
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Meryx Inc.
CENTRAL INDEX KEY: 0001606031
IRS NUMBER: 462774382
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-216349
FILM NUMBER: 14789107
BUSINESS ADDRESS:
STREET 1: 102 FLAGSTONE COURT
CITY: CHAPEL HILL
STATE: NC
ZIP: 27517
BUSINESS PHONE: 919-843-5486
MAIL ADDRESS:
STREET 1: 102 FLAGSTONE COURT
CITY: CHAPEL HILL
STATE: NC
ZIP: 27517
D/A
1
primary_doc.xml
X0707
D/A
LIVE
0001606031
Meryx Inc.
102 FLAGSTONE COURT
CHAPEL HILL
NC
NORTH CAROLINA
27517
919-843-5486
DELAWARE
None
None
Corporation
true
2013
Stephen
V.
Frye
102 Flagstone Court
Chapel Hill
NC
NORTH CAROLINA
27517
Executive Officer
Director
Biotechnology
Decline to Disclose
- 06b
true
0001606031-14-000001
2014-04-14
false
true
false
0
3100172
3100172
0
false
3
0
0
0
false
Meryx Inc.
/s/ Stephen V. Frye, Ph.D.
Stephen V. Frye, Ph.D.
President and CEO
2014-04-28